HIGHLIGHTS
- who: Nicolas Barbarot et al. from the Service de Réanimation, CH de SAINT BRI EU have published the Article: Case Report Treating Acute Severe Eosinophilic Asthma with IL-5 Inhibitors in ICU, in the Journal: Case Reports in Pulmonology of 21/08/2022
SUMMARY
About 10% of the 300 million people worldwide who suffer from asthma have a severe disease that is uncontrolled despite treatment with inhaled corticosteroids and long-acting beta agonists. The anti-IL-5 antibodies reduce the incidence of exacerbation and allowed steroid sparing in severe asthma patients but . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.